Iovance Biotherapeutics Debt 2024

Iovance Biotherapeutics Aktienanalyse

What does Iovance Biotherapeutics do?

Iovance Biotherapeutics Inc is a US biotechnology company specializing in the development of personalized immunotherapies for cancer patients. The company was founded in 2007 by Dr. Dendy Engelman and is headquartered in San Carlos, California. Iovance Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Iovance Biotherapeutics's Debt Structure

Iovance Biotherapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Iovance Biotherapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Iovance Biotherapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Iovance Biotherapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Iovance Biotherapeutics Stock

What is the debt of Iovance Biotherapeutics this year?

Iovance Biotherapeutics has a debt level of -113.89 USD this year.

What was the debt of Iovance Biotherapeutics compared to the previous year?

The debt of Iovance Biotherapeutics has increased by -50.63% compared to the previous year dropped.

What are the consequences of high debt for investors in Iovance Biotherapeutics?

High debt can pose a risk for investors of Iovance Biotherapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Iovance Biotherapeutics?

Low debt means that Iovance Biotherapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Iovance Biotherapeutics affect the company?

An increase in debt of Iovance Biotherapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Iovance Biotherapeutics affect the company?

A reduction in debt of Iovance Biotherapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Iovance Biotherapeutics?

Some factors that can influence the debt of Iovance Biotherapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Iovance Biotherapeutics so important for investors?

The debts of Iovance Biotherapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Iovance Biotherapeutics take to change the debt?

To change the debt, Iovance Biotherapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Iovance Biotherapeutics pay?

Over the past 12 months, Iovance Biotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Iovance Biotherapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Iovance Biotherapeutics?

The current dividend yield of Iovance Biotherapeutics is .

When does Iovance Biotherapeutics pay dividends?

Iovance Biotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Iovance Biotherapeutics?

Iovance Biotherapeutics paid dividends every year for the past 0 years.

What is the dividend of Iovance Biotherapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Iovance Biotherapeutics located?

Iovance Biotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Iovance Biotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Iovance Biotherapeutics from 5/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/15/2024.

When did Iovance Biotherapeutics pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Iovance Biotherapeutics in the year 2023?

In the year 2023, Iovance Biotherapeutics distributed 0 USD as dividends.

In which currency does Iovance Biotherapeutics pay out the dividend?

The dividends of Iovance Biotherapeutics are distributed in USD.